Sermorelin

Sermorelin Acetate is an artificial analog of human growth hormone (GHRH), focusing on first 29 of its 44 amino acids. Produced in the early 1980s and FDA-approved in 1997, it was introduced by Serono under the brand name Geref. Primarily used as a diagnostic tool for hypophysis deficiencies, it also gained approval for treating growth hormone deficiency in children. Though discontinued in 2008 due to supply issues, compounded versions remain available. It stimulates the pituitary gland, increasing natural growth hormone production without excessive levels.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.